Neurokinin A increases duodenal mucosal permeability, bicarbonate secretion, and fluid output in the rat

被引:11
作者
Hallgren, A [1 ]
Flemstrom, G [1 ]
Hellstrom, PM [1 ]
Lordal, M [1 ]
Hellgren, S [1 ]
Nylander, O [1 ]
机构
[1] KAROLINSKA HOSP, DEPT MED, S-17176 STOCKHOLM, SWEDEN
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 1997年 / 273卷 / 05期
关键词
duodenum; motility; neurokinin-2 receptor antagonist; tachykinin; cyclooxygenase inhibitor;
D O I
10.1152/ajpgi.1997.273.5.G1077
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this study was to examine the integrative response to neurokinin A (NKA) on duodenal mucosal permeability, bicarbonate secretion, fluid flux, and motility in an in situ perfusion model in anesthetized rats. Intravenous infusion of NKA. (100, 200, and 400 pmol.kg(-1).min(-1)) induced duodenal motility. Furthermore, duodenal mucosal bicarbonate secretion, fluid output, and mucosal permeability increased in response to NKA. Pretreatment with the nicotinic antagonist hexamethonium did not change the response in any of the parameters investigated, whereas the NK2-receptor antagonist MEN 10,627 effectively inhibited all responses to NKA. Indomethacin induced duodenal motility and stimulated bicarbonate secretion. In indomethacin-treated rats, NKA further increased motility but decreased indomethacin-stimulated bicarbonate secretion by 70%. The NKA-induced increase in mucosal permeability was unaltered by indomethacin. It is concluded that NKA not only induces motility but also increases mucosal permeability and fluid output. Furthermore, the neuropeptide may have both stimulative and inhibitory effects on bicarbonate secretion. All responses to NKA. are dependent on NK-2 receptor activation but are not mediated through nicotinic receptors.
引用
收藏
页码:G1077 / G1086
页数:10
相关论文
共 22 条
[1]   GASTRODUODENAL MUCOSAL PROTECTION [J].
ALLEN, A ;
FLEMSTROM, G ;
GARNER, A ;
KIVILAAKSO, E .
PHYSIOLOGICAL REVIEWS, 1993, 73 (04) :823-857
[2]  
BENTZEL CJ, 1992, TIGHT JUNCTIONS, P151
[3]  
BERGSTROM L, 1987, MOL PHARMACOL, V32, P764
[4]   NOVEL PHARMACOLOGY OF SUBSTANCE-K-BINDING SITES - A 3RD TYPE OF TACHYKININ RECEPTOR [J].
BUCK, SH ;
BURCHER, E ;
SHULTS, CW ;
LOVENBERG, W ;
ODONOHUE, TL .
SCIENCE, 1984, 226 (4677) :987-989
[5]  
BURCHER E, 1986, J PHARMACOL EXP THER, V236, P819
[6]  
Dockray Graham J., 1994, P169
[7]   RECOMBINANT BOVINE NEUROKININ-2 RECEPTOR STABLY EXPRESSED IN CHINESE-HAMSTER OVARY CELLS COUPLES TO MULTIPLE SIGNAL TRANSDUCTION PATHWAYS [J].
EISTETTER, HR ;
CHURCH, DJ ;
MILLS, A ;
GODFREY, PP ;
CAPPONI, AM ;
BREWSTER, R ;
SCHULZ, MF ;
KAWASHIMA, E ;
ARKINSTALL, SJ .
CELL REGULATION, 1991, 2 (10) :767-779
[8]  
Flemstrom Gunnar, 1994, P1285
[9]   Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract [J].
Grady, EF ;
Baluk, P ;
Bohm, S ;
Gamp, PD ;
Wong, H ;
Payan, DG ;
Ansel, J ;
Portbury, AL ;
Furness, JB ;
McDonald, DM ;
Bunnett, NW .
JOURNAL OF NEUROSCIENCE, 1996, 16 (21) :6975-6986
[10]   EFFECTS OF NITRIC-OXIDE INHIBITION ON DUODENAL FUNCTION IN RAT - INVOLVEMENT OF NEURAL MECHANISMS [J].
HALLGREN, A ;
FLEMSTROM, G ;
SABABI, M ;
NYLANDER, O .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 269 (02) :G246-G254